Clinical phenotypes within the described inclusion‐body myopathy kindreds included both ALS/FTD features and two cases of FTD, indicating that ANXA11 mutations can cause a variety of distinct phenotypes within the FTD/ALS/inclusion‐body myopathy disease spectrum. The gene discussed is ANXA11; the disease is frontotemporal dementia.